Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.

Authors

Ronald Goldberg, University of Miami
Marinella G. Temprosa, George Washington University
Trevor J. Orchard, University of Pittsburgh
Lisa L. Mele, George Washington University
Kieren J. Mather, Indiana University
George A. Bray, Pennington Biomedical Research Center, Baton Rouge, LA
Edward Horton, Joslin Diabetes Center, Boston, MA
Abbas E. Kitabchi
Jonathan Krakoff
Santica M. Marcovina, Northwest Lipid Research Laboratories
Leigh Perreault, University of Colorado
Neil H. White, Washington University in St. Louis

Document Type

Journal Article

Publication Date

5-1-2016

Journal

Metabolism

Volume

65

Issue

5

Inclusive Pages

764-75

DOI

10.1016/j.metabol.2015.11.011

APA Citation

Goldberg, R., Temprosa, M. G., Orchard, T. J., Mele, L. L., Mather, K. J., Bray, G. A., Horton, E., Kitabchi, A. E., Krakoff, J., Marcovina, S. M., Perreault, L., & White, N. H. (2016). Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.. Metabolism, 65 (5). http://dx.doi.org/10.1016/j.metabol.2015.11.011

Peer Reviewed

1